港股异动 | 中国生物制药(01177)涨超6% 公司重申年内收入指引 新获批创新药将是销售持续放量主要动力
Last Update:
21 9 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.